| Income Statement |
| Total Revenue | 14.77M |
|
| Revenues (USD) | 14.77M |
| Cost of Revenue | 1.89M |
| Gross Profit | 12.88M |
| Operating Expenses | 25.04M |
| Research and Development Expense | 3.08M |
| Selling, General and Administrative Expense | 21.96M |
| Operating Income | -12.16M |
| Interest Expense | 1.55M |
| Income Tax Expense | 1000 |
| Net Income | -13.12M |
| Net Income Common Stock | -13.12M |
| Net Income Common Stock (USD) | -13.12M |
| Consolidated Income | -13.12M |
| Earnings per Basic Share | -0.50 |
| Earnings per Basic Share (USD) | -0.50 |
| Earnings per Diluted Share | -0.50 |
| Earning Before Interest & Taxes (EBIT) | -11.57M |
| Earning Before Interest & Taxes (USD) | -11.57M |
| Weighted Average Shares | 26.36M |
| Weighted Average Shares Diluted | 26.36M |
| Balance Sheet |
| Cash and Equivalents | 72.30M |
| Cash and Equivalents (USD) | 72.30M |
| Trade and Non-Trade Receivables | 9.10M |
| Current Assets | 96.75M |
| Property, Plant & Equipment Net | 2.95M |
| Total Assets | 99.73M |
| Total Debt | 59.03M |
| Current Liabilities | 9.49M |
| Debt Non-Current | 59.03M |
| Total Liabilities | 70.62M |
| Accumulated Retained Earnings (Deficit) | -603.77M |
| Accumulated Other Comprehensive Income | -203.00K |
| Shareholders Equity | 29.11M |
| Shareholders Equity (USD) | 29.11M |
| Assets Non-Current | 2.98M |
| Total Debt (USD) | 59.03M |
| Inventory | 12.40M |
| Liabilities Non-Current | 61.13M |
| Trade and Non-Trade Payables | 3.00M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 205.00K |
| Net Cash Flow from Financing | 8.88M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.40M |
| Capital Expenditure | -122.00K |
| Issuance (Purchase) of Equity Shares | -11.00K |
| Issuance (Repayment) of Debt Securities | 10.00M |
| Net Cash Flow from Investing | -122.00K |
| Net Cash Flow from Operations | -12.16M |
| Effect of Exchange Rate Changes on Cash | -1000 |
| Share Based Compensation | 2.92M |